The new Bactiguard-CEO Christine Lind brings extensive strategic and operational experience from more than 25 years in the healthcare sector. She has held CEO and executive level positions in business development and strategy at biotech companies including BioArctic AB, Medivir AB and LifeCell Corporation. Her last stop before Bactiguard was SSI Strategy/NDA Group AB. There she was Senior Vice President Corporate Development. Prior to that, she spent a decade as an investment banker at Merril Lynch, advising biotech and pharmaceutical companies on licensing, M&A and financing. Lind holds a BSc in Finance & Information Systems from New York University and an MBA from Columbia Business School.